KNTE
Kinnate Biopharma is a precision oncology company dedicated to creating selective small molecules that target specific genetic mutations and fusions. The company aims to address unmet medical needs in cancer treatment and operates primarily in the biopharmaceutical sector, focusing on innovative therapies.
No recent deals for this company.